NCT05647135

Brief Summary

This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.

  • Differences regarding achieving protein and calorie daily targets when using enteral nutrition formulas with different protein content
  • Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content
  • Differences regarding body composition when using enteral nutrition formulas with different protein content

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

1.8 years

First QC Date

November 1, 2022

Last Update Submit

July 17, 2024

Conditions

Keywords

enteral nutritionmultiple traumaenergy targetprotein targetbody compositiongastric residual volumeenteral nutrition intolerance

Outcome Measures

Primary Outcomes (2)

  • Calorie and protein target

    Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content

    on day 5 days

  • Calorie and protein target

    Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content

    on day 10

Secondary Outcomes (18)

  • Ultrasound-guided assessment of gastric residual volume

    on day 5

  • Ultrasound-guided assessment of gastric residual volume

    on day 10

  • Muscle function

    24 hours after extubation

  • Muscle function

    5 days after extubation

  • Body composition - Fat-free body mass

    24 hours after extubation

  • +13 more secondary outcomes

Study Arms (2)

Group A

Group A - enteral formula with 6.3 g/100 ml protein

Other: Medical food

Group B

enteral formula with 10 g/100 ml protein

Other: Medical food

Interventions

enteral formulas with different protein composition

Group AGroup B

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU)

You may qualify if:

  • Adult patients (\>18 yrs) admitted to the ICU
  • Multiple trauma (Injury severity score \> 18)
  • Intubation and mechanical ventilation upon admission in ICU or during the first 24 hours of admission, for at least 48 h

You may not qualify if:

  • Age \< 18 years
  • Pregnant women
  • Patients not intubated or not mechanically ventilated or receiving only non-invasive ventilation
  • Patients with enteral feeding contraindication 48 h after admission
  • Patients with recent gastrointestinal surgical intervention
  • Patients on chronic therapy with corticosteroids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Emergency Hospital of Bucharest

Bucharest, Romania

RECRUITING

Related Publications (5)

  • van Zanten ARH, Petit L, De Waele J, Kieft H, de Wilde J, van Horssen P, Klebach M, Hofman Z. Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial. Crit Care. 2018 Jun 12;22(1):156. doi: 10.1186/s13054-018-2070-5.

  • Singer P. Protein metabolism and requirements in the ICU. Clin Nutr ESPEN. 2020 Aug;38:3-8. doi: 10.1016/j.clnesp.2020.03.026. Epub 2020 May 31.

  • Tedeschi-Jockers F, Reinhold S, Hollinger A, Tuchscherer D, Kiss C, Gantner L, Ledergerber K, Zimmermann S, Scheuzger J, Huber J, Siegemund M. A new high protein-to-energy enteral formula with a whey protein hydrolysate to achieve protein targets in critically ill patients: a prospective observational tolerability study. Eur J Clin Nutr. 2022 Mar;76(3):419-427. doi: 10.1038/s41430-021-00956-9. Epub 2021 Jun 24.

  • Berger MM, Reintam-Blaser A, Calder PC, Casaer M, Hiesmayr MJ, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Bischoff SC, Singer P. Monitoring nutrition in the ICU. Clin Nutr. 2019 Apr;38(2):584-593. doi: 10.1016/j.clnu.2018.07.009. Epub 2018 Jul 20.

  • Yasuda H, Kondo N, Yamamoto R, Asami S, Abe T, Tsujimoto H, Tsujimoto Y, Kataoka Y. Monitoring of gastric residual volume during enteral nutrition. Cochrane Database Syst Rev. 2021 Sep 27;9(9):CD013335. doi: 10.1002/14651858.CD013335.pub2.

MeSH Terms

Conditions

Wounds and InjuriesMalnutritionKwashiorkorGastroparesisMuscular AtrophyProtein-Energy MalnutritionMultiple Trauma

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesSevere Acute MalnutritionStomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeuromuscular ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalProtein DeficiencyDeficiency Diseases

Study Officials

  • Ioana Grintescu, MD, PhD

    Romanian Society of Enteral and Parenteral Nutrition

    STUDY DIRECTOR

Central Study Contacts

Ioana Grintescu, MD, PhD

CONTACT

Cristian Cobilinschi, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
8 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2022

First Posted

December 12, 2022

Study Start

March 1, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Data requests can be submitted by researchers in the field of clinical nutrition starting 9 months after article publication and the data will be made accessible for up to 3 years. Extensions will be considered on a case-by-case basis

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
2024 3 years
Access Criteria
Interest in data analysis, appropriate background in the field

Locations